For the Inventor, By the Inventor

Enter assignee name

Marseilles, France

Trophos

USPTO Granted Patents = 15

CIPO Patents = 11

EPO Patents = 7

Forward Citations = 15

Loading Chart...

Loading Chart...

17 inventors (with patents filed for the assignee):

Cyrille Drouot (9 out of 9 patents)

Thierry Bordet (7 out of 7 patents)

Bruno Buisson (6 out of 6 patents)

4. Rebecca Pruss (5 out of 5 patents)

5. Corinne Chaimbault (3 out of 3 patents)

6. Michel Delaage (3 out of 15 patents)

7. Pascal Villa (2 out of 2 patents)

8. Toni Williamson (2 out of 2 patents)

9. Laure Jamot (1 out of 3 patents)

10. Abdesslamc Nazih (1 out of 1 patent)

11. Cyrillo Drouot (1 out of 1 patent)

12. Abdesslame Nazih (1 out of 1 patent)

13. Céline Simon (1 out of 1 patent)

14. Delphine Maux (1 out of 1 patent)

15. Christopher Henderson (1 out of 2 patents)

15 patents: Sort by Forward Citations

1. 9447140 - Cholest-4-en-3-one oxime derivatives, pharmaceutical compositions containing same, and preparation method (2016-09-20),

2. 9320745 - Use of cholest-4-en-3-one derivatives for obtaining a cytoprotective drug (2016-04-26),

3. 9115059 - Oxime derivatives of 3,5-seco-4-nor-cholestane, pharmaceutical compositions containing same, and method for preparing same (2015-08-25),

4. 9045393 - Derivatives of 3.5-seco-4-norcholestane and use thereof (2015-06-02),

5. 8691854 - Chemical compounds and the uses thereof as a medicine (2014-04-08),

6. 8575138 - Method for providing neuroprotection (2013-11-05),

7. 8481515 - Derivatives of cholest-4-en-3-one oxime, pharmaceutical compositions containing them and preparation method (2013-07-09),

8. 8354395 - Method for providing neuroprotection from spinal muscular atrophy (2013-01-15),

9. 8338488 - Use of at least one oxime derivative of 3,5-seco-4-nor-cholestane as antioxidants (2012-12-25),

10. 8283341 - Use as medicaments of derivatives of cholest-4-en-3-one, pharmaceutical compositions containing them, novel derivatives and their preparation process (2012-10-09),

11. 7985774 - Use of 3,5-seco-4-nor-cholestane derivatives for obtaining a cytoprotective drug (2011-07-26),

12. 7858603 - Use of derivatives of cholest-4-en-3-one as medicaments, pharmaceutical compositions containing same, novel derivatives and preparation method thereof (2010-12-28),

13. 7372626 - Device for sequential observation of samples and methods using same (2008-05-13),

14. 7072105 - Device for positioning a plate used for analyzing samples on an examination device (2006-07-04),

15. 6949354 - Methods for screening compounds active on neurons (2005-09-27),

TROPHOS is a biopharmaceutical company specializing in the development of innovative therapeutics for neurodegenerative disorders. With a focus on mitochondrial dysfunctions, TROPHOS aims to address the unmet medical needs of patients suffering from debilitating diseases such as amyotrophic lateral sclerosis (ALS), spinal muscular atrophy (SMA), and Parkinson's disease. Through extensive research and clinical trials, TROPHOS strives to provide effective treatments that improve the quality of life for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

15 Patents

#6 in Marseilles

#1,225 in France

#38,669 in the World

Marseilles, France

Trophos

Forward Citations = 15

17 inventors:

Cyrille Drouot (9 out of 9 patents)

Thierry Bordet (7 out of 7 patents)

Bruno Buisson (6 out of 6 patents)

4. Rebecca Pruss (5 out of 5 patents)

5. Corinne Chaimbault (3 out of 3 patents)

Please report any incorrect information to support@idiyas.com

Loading…